Table 3.
Primary diagnosis at study enrollment
Diagnosis
.
PCT-FFP, no. (%); n = 60
.
C-FFP, no. (%); n = 61
.
Cirrhosis
45 (75)
47 (77)
Acute hepatitis
1 (2)
1 (2)
Hepatocellular carcinoma
1 (2)
0 (0)
Multisystem organ failure
0 (0)
1 (2)
Warfarin reversal
2 (3)
1 (2)
Other
11 (18)
11 (18)
Diagnosis
.
PCT-FFP, no. (%); n = 60
.
C-FFP, no. (%); n = 61
.
Cirrhosis
45 (75)
47 (77)
Acute hepatitis
1 (2)
1 (2)
Hepatocellular carcinoma
1 (2)
0 (0)
Multisystem organ failure
0 (0)
1 (2)
Warfarin reversal
2 (3)
1 (2)
Other
11 (18)
11 (18)
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal